Explain this page
Arphra AIPlain-English read on Caribou Biosciences, Inc.’s valuationNo recent stories.
today
- Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 202614d
- Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 202614d
- Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting14d
- Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting14d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $5.00 (+201.20%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00% | +1.84% | -23.15% | -11.70% | -2.35% | +4.40% | +16.90% | -59.31% | -89.83% | -89.83% | -89.83% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$1.66
Bid
$1.61
172 sh
Ask
$1.72
40,000 sh
Spread
$0.110
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Consumer Cyclical+1.37%
- Technology+1.17%
- Utilities+0.96%
- Financial Services+0.65%
- Basic Materials+0.59%
- Industrials+0.54%
- Consumer Defensive+0.42%
- Energy-0.18%
- Communication Services-0.40%
- Healthcare-0.41%
- Real Estate-0.54%
Top industries (issuer's industry highlighted)
- Biotechnology+9.63%
- Software - Services-7.11%
- Business Equipment & Supplies+6.51%
- Financial - Mortgages+4.52%
- Furnishings, Fixtures & Appliances+4.34%
- Home Improvement+3.89%
- Construction+3.62%
- Paper, Lumber & Forest Products+3.53%
- Discount Stores+3.53%
- Medical - Diagnostics & Research+3.31%
- Financial - Conglomerates+3.03%
- REIT - Hotel & Motel+2.92%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026globenewswire.com·Jun 11, 2026
- Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026globenewswire.com·Jun 11, 2026
- Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meetingglobenewswire.com·Jun 11, 2026
- Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meetingglobenewswire.com·Jun 11, 2026
- Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meetingglobenewswire.com·Jun 11, 2026
- Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 05, 2026
- Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conferenceglobenewswire.com·May 13, 2026
- Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conferenceglobenewswire.com·May 13, 2026
Peers
No peer list available for CRBU.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|